.png)
Clinical Studies
SVG Pharma supports sponsor-led clinical studies across medicinal cannabis and selected emerging therapeutic areas within Australia's regulated research environment.
​
Information provided for professional and scientific context only. All studies are conducted in accordance with Australian regulatory and ethics requirements. Data ownership and rights of publication and further dissemination are retained by the respective data owners.
.png)
GENESIS STUDY
A Phase III clinical evaluation of cannabidiol for IBS-related abdominal pain
​
Study Phase & Design: Phase III, double-blind, randomised, placebo-controlled
Therapeutic Area: Gastroenterology / Medicinal Cannabis
Investigational Product: Cannabidiol oral oil formulation (CBD100)
Study Sponsor / CRO: SVG Pharma
Principal Investigator: Dr Chris Schneider
Data Owner: Genetrax Pty Ltd (ABN 80 663 505 593)
Investigational Product Supplier: Australian Natural Therapeutics Group (ANTG)
Geography: Australia
Study Status: Completed (January 2025)
​
Outcomes
The study has been completed in accordance with the approved protocol and Good Clinical Practice guidelines. A full clinical dataset has been generated.
​
Ownership of the study data and rights to publication and further dissemination are held by Genetrax Pty Ltd.
​​​​
Study information is provided for professional and scientific context only and does not constitute promotional claims regarding any therapeutic product.
METADORA STUDY
A Phase II investigation of a cannabinoid-based therapy for dysmenorrhea
​
Study Phase & Design: Phase II, double-blind, randomised comparison study
Therapeutic Area: Women’s Health / Medicinal Cannabis
Investigational Product: Cannabinoid-based therapeutic
Study Sponsor: NektarTek Pty Ltd
Principal Investigator: Dr Chris Schneider
Geography: Tasmania and Victoria
Study Status: Ethics and regulatory approvals in progress
​
Participant eligibility and recruitment will proceed strictly in accordance with approved ethics and site protocols. Study information is provided for professional and scientific context only and does not constitute promotional claims.